Department of Clinical Chemistry, Central Diagnostic Laboratory, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands.
ILD Care Foundation Research Team, 6711 NR Ede, The Netherlands.
Int J Mol Sci. 2019 Mar 7;20(5):1160. doi: 10.3390/ijms20051160.
Here, we describe a Dutch family with idiopathic pulmonary fibrosis (IPF). We hypothesized that there might be an association between the presence of Vitamin K epoxide reductase complex 1 () and/or cytochrome P450 variant alleles and the early onset of IPF in the members of this family. (rs9923231 and rs9934438) and (rs1799853 and rs1057910) were genotyped in this family, which includes a significant number of pulmonary fibrosis patients. In all family members, at least one of the variant alleles tested was present. The presence of the variant alleles in all of the IPF cases and variants in all but one, which likely leads to a phenotype that is characterized by the early onset and progressive course of IPF. Our findings indicate a role of these allelic variants in (familial) IPF. Therefore, we suggest that the presence of these variants, in association with other pathogenic mutations, should be evaluated during genetic counselling. Our findings might have consequences for the lifestyle of patients with familial IPF in order to prevent the disease from becoming manifest.
在这里,我们描述了一个荷兰特发性肺纤维化(IPF)家族。我们假设,维生素 K 环氧化物还原酶复合物 1 () 和/或细胞色素 P450 变异等位基因的存在可能与该家族成员中 IPF 的早期发病有关。对该家族中的 (rs9923231 和 rs9934438) 和 (rs1799853 和 rs1057910) 进行了基因分型,该家族包括大量肺纤维化患者。在所有家族成员中,至少存在一种测试的变异等位基因。所有 IPF 病例均存在 变异等位基因,除一例外,所有病例均存在 变异基因,这可能导致 IPF 的早期发病和进行性病程的表型。我们的研究结果表明这些等位基因变异在(家族性)特发性肺纤维化中起作用。因此,我们建议在遗传咨询期间,应评估这些变体与其他致病突变的存在。我们的研究结果可能会对家族性 IPF 患者的生活方式产生影响,以预防疾病的发生。